Abstract:Rat forebrain ischemia followed by a 3-day reperfusion led to an increase in the levels of the autophagic marker LC3B-II and glial fibrillary acidic protein (GFAP), as well as caspase-3 activation, in the hippocampus and frontal cortex of the rat brain. Meanwhile, intranasal administration of 0.5 IU insulin to rats with forebrain ischemia/reperfusion (I/R) injury (once before ischemic exposure and once a day during 3-day reperfusion) significantly diminished the LC3B-II level and caspase-3 activity in the hippocampus and frontal cortex, thus demonstrating the ability of intranasal insulin to inhibit autophagy and apoptosis activation in the forebrain structures during I/R. A significant intranasal insulin-mediated reduction in the GFAP level within the same brain structures failed to be detected. Intranasal insulin administration activated Akt protein kinase (which activates mTORC1, an autophagy inhibitor) and inhibited AMPK protein kinase (an autophagy activator) in the hippocampus and cerebral cortex of rats with forebrain I/R injury, which is likely to underlie the ability of intranasal insulin to reduce autophagic and apoptotic neuronal death. The data on the in vivo intranasal insulin-mediated modulation of Akt and AMPK activities are consistent with our previous results on the possible mechanism of insulin neuroprotection, obtained in vitro on rat cortical neurons exposed to oxidative stress.

Intranasal Insulin Administration to Rats with Forebrain Ischemia and Reperfusion Injury Reduces Autophagy and Apoptosis Intensity in the Hippocampus and Frontal Cortex, a Possible Mechanism of Action